Clearstead Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Clearstead Advisors, LLC

  • $7.4 Billion
  • Q3 2025

A detailed history of Clearstead Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 885 shares of REGN stock, worth $613,747. This represents 0.01% of its overall portfolio holdings.

Number of Shares
885
Previous 439 101.59%
Holding current value
$613,747
Previous $230,000 116.09%
% of portfolio
0.01%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025
BUY
$534.91 - $598.71 $238,569 - $267,024
446 Added 101.59%
885 $497,000
Q2 2025

Aug 08, 2025
SELL
$483.07 - $625.6 $54,103 - $70,067
-112 Reduced 20.33%
439 $230,000
Q1 2025

May 13, 2025
BUY
$634.14 - $744.83 $25,999 - $30,538
41 Added 8.04%
551 $349,000
Q4 2024

Feb 10, 2025
BUY
$701.85 - $1046.91 $20,353 - $30,360
29 Added 6.03%
510 $363,000
Q3 2024

Nov 13, 2024
SELL
$1024.09 - $1201.76 $23,554 - $27,640
-23 Reduced 4.56%
481 $505,000
Q2 2024

Aug 09, 2024
BUY
$883.2 - $1071.19 $62,707 - $76,054
71 Added 16.4%
504 $529,000
Q1 2024

May 14, 2024
SELL
$902.69 - $993.35 $41,523 - $45,694
-46 Reduced 9.6%
433 $416,000
Q4 2023

Feb 12, 2024
BUY
$775.18 - $881.7 $13,178 - $14,988
17 Added 3.68%
479 $420,000
Q3 2023

Nov 07, 2023
SELL
$692.45 - $844.37 $11,771 - $14,354
-17 Reduced 3.55%
462 $380,000
Q2 2023

Aug 07, 2023
BUY
$700.03 - $830.35 $17,500 - $20,758
25 Added 5.51%
479 $344,000
Q1 2023

May 09, 2023
BUY
$680.49 - $826.97 $87,102 - $105,852
128 Added 39.26%
454 $373,000
Q4 2022

Feb 14, 2023
BUY
$705.89 - $766.39 $19,059 - $20,692
27 Added 9.03%
326 $235,000
Q4 2021

Feb 14, 2022
BUY
$543.48 - $670.97 $117,935 - $145,600
217 Added 264.63%
299 $189,000
Q2 2021

Aug 12, 2021
SELL
$472.8 - $558.54 $10,401 - $12,287
-22 Reduced 21.15%
82 $46,000
Q1 2021

May 14, 2021
BUY
$446.73 - $548.2 $15,635 - $19,187
35 Added 50.72%
104 $49,000
Q4 2020

Feb 11, 2021
BUY
$478.3 - $607.98 $956 - $1,215
2 Added 2.99%
69 $33,000
Q3 2020

Nov 12, 2020
BUY
$544.75 - $658.21 $8,171 - $9,873
15 Added 28.85%
67 $38,000
Q1 2020

May 14, 2020
BUY
$336.18 - $494.43 $17,481 - $25,710
52 New
52 $25,000

Others Institutions Holding REGN

# of Institutions
1,466
Shares Held
86.5M
Call Options Held
2.38M
Put Options Held
1.61M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $74.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Clearstead Advisors, LLC Portfolio

Follow Clearstead Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email